Publié le Laisser un commentaire

New Epigenetic Clock Built on Lurking DNA Fragments

In Aging Cell, a team of researchers has announced Retroelement-Age, a novel clock that focuses on the expression of buried pieces of DNA that are normally suppressed.

Corrupted but unexpressed

The natural human genome has a large number of artifacts left over from ancient viral infections along with pieces of DNA that transpose themselves into the genome. These human endogenous retroviruses (HERVs) and long interspersed nuclear elements (LINEs) make up a surprisingly large portion of the human genome [1].

Most of these retroelements are normally suppressed by epigenetics: the DNA is simply never translated into RNA, and so they lie dormant. However, epigenetic alterations can drive them out of dormancy, and this can have harmful consequences [2], some of which are related to further aging [3]. Because this epigenetic uncovering has harmful, age-related consequences, these researchers decided to build an epigenetic clock out of it.

A new model built on a new system

To begin building the first version of Retroelement-Age, the researchers used MethylationEPIC version 1.0, a standard methylation analysis platform, and then discovered that 10,917 epigenetic CpG sites were on HERVs and LINEs. Then, they pulled epigenetic data from a set of 12,670 people with ages ranging from 12 to 100. After cross-validation, the researchers’ elastic net algorithm determined that 1,317 of these CpG sites were useful in guessing chronological age with high accuracy.

However, with the development of MethylationEPIC version 2.0, the researchers sought to create a clock that used this latest version with updated methylation information. This clock, which considered 1,378 CpG sites to be of use, was even stronger than the first version, which the researchers ascribe to the newer version of MethylationEPIC having more reliable probes [4]. These findings were additionally confirmed by entirely separate datasets involving blood cells.

There was no overlap at all between the CpG sites of Retroelement-Age and most previous clocks, including first-generation clocks such as Horvath and Hannum along with the later PhenoAge and GrimAge and the Dunedin Pace of Aging clock. The only commonalities were found between the second version of Retroelement-Age and nine CpG sites used in AdaptAge, CausAge, and DamAge, a trio of clocks built around sites that were found to be causal in aging [5].

Antiretroviral therapies, which are used in the treatment of HIV, were able to significantly reduce the Retroelement-Age of the treated groups. The researchers suggest that this is because these therapies also suppress HERVs. However, there was no trial undertaken to determine if antiretroviral therapies reduce Retroelement-Age in the absence of HIV.

Epigenetic reprogramming, a known method of rejuvenating the epigenetics of cells, was found to successfully rejuvenate fibroblasts as measured by both versions of Retroelement-Age, but this did not work in endothelial cells. The researchers concluded that responses to this reprogramming are cell-type specific.

The researchers then concluded their paper with information on a multi-tissue version and a pan-mammalian version of their novel clock. Like with their original clock, the pan-mammalian version did not overlap with the sites used by any previous clocks.

Ultimately, this clock does more than just measure age: it identifies problems that are known to lead to age-related diseases. It is as of yet unclear whether it is feasible to develop approaches that can silence, or even permanently remove, dangerous elements in the genome.

Together, these findings support the hypothesis of dysregulation of endogenous retroelements as a potential contributor to the biological hallmarks of aging and suggest that therapeutic interventions modifying the epigenetic states of specific retroelements in the human genome could have beneficial effects against a root cause of aging and disease.

We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. We are committed to responsible journalism, free from commercial or political influence, that allows you to make informed decisions about your future health.

All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future. You can support us by making a donation or in other ways at no cost to you.

Literature

[1] Nurk, S., Koren, S., Rhie, A., Rautiainen, M., Bzikadze, A. V., Mikheenko, A., … & Phillippy, A. M. (2022). The complete sequence of a human genome. Science, 376(6588), 44-53.

[2] Dopkins, N., & Nixon, D. F. (2024). Activation of human endogenous retroviruses and its physiological consequences. Nature Reviews Molecular Cell Biology, 25(3), 212-222.

[3] Zhang, H., Li, J., Yu, Y., Ren, J., Liu, Q., Bao, Z., … & Liu, G. H. (2023). Nuclear lamina erosion-induced resurrection of endogenous retroviruses underlies neuronal aging. Cell reports, 42(6).

[4] Noguera-Castells, A., García-Prieto, C. A., Álvarez-Errico, D., & Esteller, M. (2023). Validation of the new EPIC DNA methylation microarray (900K EPIC v2) for high-throughput profiling of the human DNA methylome. Epigenetics, 18(1), 2185742.

[5] Ying, K., Liu, H., Tarkhov, A. E., Sadler, M. C., Lu, A. T., Moqri, M., … & Gladyshev, V. N. (2024). Causality-enriched epigenetic age uncouples damage and adaptation. Nature aging, 4(2), 231-246.

Publié le Laisser un commentaire

Longevity and DeSci Recap – July 2024

The Longevity and DeSci Recap is back, and our latest edition covers high-profile events including the Longevity Investors Conference in Gstaad, new innovations in AFib monitoring, and even some celebrity-related news. This month, we’ll continue to explore the latest events, current research, and investment news to give you a complete round-up of the current landscape of longevity and decentralized science (DeSci).

Upcoming conferences and events

Inhibiting IL-11 with Dr. Oliver Medvedik

The Journal Club returns to Lifespan.io’s Facebook page this August 9th. Join us live at 12 Eastern Time to catch up with the latest on how inhibiting IL-11 increases mouse lifespan by about a quarter. Dr. Oliver Medvedik will discuss how the IL-11 receptor protects against age-related diseases in mice and could have potential in extending human lifespan as well. Lifespan Heroes can join the event for free and participate directly.

11th session of the Aging Research and Drug Discovery Meeting

On the 26th and 30th of this month, you can join Nir Barzilai, Vera Gorbunova, Aubrey de Grey and a host of other industry names at the 11th edition of the Aging Research and Drug Discovery Meeting. In this long-awaited event, participants will discuss interventions for age-related diseases, longevity, and so much more. Tickets are available here.

Gstaad, Switzerland plays host to the most exclusive event of the year

Once a year, the world’s longevity elite, including top investors, meet in Switzerland to discuss market movements and pave the way for the industry’s future. This year’s event is no exception and is set to be a captivating networking experience. Attendees are carefully chosen, with all investors welcome to apply for tickets here.

HLTH 2024: health is back on stage in Vegas

It’s lights, cameras, action as the US edition of the HLTH 2024 conference hits the stage in Las Vegas. Like previous years, this is set to be one of the biggest events in healthcare and will cover topics such as AI in healthcare, longevity, and marketing. Speakers are set to include Johnson & Johnson CEO Joaquin Duato, Vice President of Healthcare and Life Sciences at NVIDIA Kimberly Powell, Cleveland Clinic CEO Tom Mihaljevic, and many more speakers combining healthcare with technology on a whole new level. Tickets for the event are still available online.

Tech breakthroughs & new research

Heart health could be just a ring away

Smart watches have long been upgraded to have new health-monitoring features, but this isn’t the only way to track vitals. Ultrahuman’s team has started designing a new wearable solution for heart monitoring: a simple ring. Now the company has secured a massive $35 million in funding to follow this project and have launched a solution called ‘PowerPlugs’. Among this batch is a plugin designed to catch atrial fibrillation, which occurs in 12.2 million people in the US.

TruDiagnostic turns reality TV

At Lifespan.io, it’s not often we get to discuss the world of celebrity, but this month, two have caught our eye: Bryan Johnson and Kim Kardashian. However, it’s not all glamor. Kim and her reality-tv family took a longevity test to assess epigenetic markers related to aging. According to the results, TV’s most famous family ended up looking, feeling, and being younger than their biological age. This had sparked a renewed interest in the field and its future potential.

DAOs and communities

VitaDAO’s community joined in for a data drop by Artan Bio

As part of VitaDAO’s ongoing collaborations, the biotech DAO hosted an event to unveil data from VitaRNA by Artan Bio. This marks a major milestone in longevity research and offers a boost to the longevity community. At this event, participants were able to learn insights into gene therapies and discover ways to target aging while engaging directly with researchers.

$BIO tokens to drop on this August

Bio.xyz announced on its Twitter that on August 8th, the DAO’s signature $BIO token will launch live. This will mark the opportunity for the DAO’s supporters and token holders to exchange their bioDAO tokens, among others, for $BIO in a genesis swap.

VitaDAO celebrates its 3rd birthday, marking a new wave in DeSci

Three years ago, VitaDAO, one of the first longevity DAOs, was formed, marking a shift in the scientific world. As the community passes this significant milestone, it’s time to acknowledge its achievements, as this DAO has evaluated 200+ longevity projects, funded 23, and allocated over $4.5 million in funding, all while paving the way for those who come next. This biotech DAO is also noted as being the 2nd DAO most worth investing in on Tracxn.

Other DeSci and longevity news

$15 million for Oisín Biotechnologies’ longevity pharma project

Age-related fragility is said to affect as many as 17% of older adults in the US today. Oisín Biotechnologies is seeking out a solution. Having just acquired $15 million in Series A funding led by AbbVie Ventures, the biotech is developing pharmaceutical solutions for frailty by improving muscle mass and eliminating unwanted fat cells to improve human healthspan.

$400 million funding investment for the Hevolution Foundation

The longevity investment branch has just announced that it will invest over $400 million in healthcare. This move would make it one of the largest philanthropic contributors in geroscience, giving it the potential to impact the lives of others, including programs to support researchers’ interest in aging globally and particularly in Latin America.

Michael J. Fox Foundation awards $6 million grant to Lario Therapeutics

Biopharmaceutical company Lario Therapeutics has just secured a grant of $6 million to pursue precision medicines for neurological conditions. The company says that the latest funding will go towards preclinical research on Lario’s CaV2.3 calcium channel inhibitors and the protection that they could potentially offer against Parkinson’s disease, among others.

Social media pages to follow this month

Niklas Anzinger — CEO of Vitalia and founder of Infinita VC. Follow for longevity and investment-related posts.

Bryan Johnson — This month, our very own Arkadi Mazin gave his take on Bryan Johnson’s blueprint of longevity. Now it’s time to follow directly to learn the latest.

Foresight Institute — Offers some of the latest investment news in the longevity sector worldwide.

We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. We are committed to responsible journalism, free from commercial or political influence, that allows you to make informed decisions about your future health.

All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future. You can support us by making a donation or in other ways at no cost to you.

Publié le Laisser un commentaire

Vegan Diet Lowers Biological Age in a New Study

In a study that involved pairs of identical twins, Stanford scientists have shown that a healthy vegan diet leads to a decrease in biological age and possibly to other health benefits [1].

Do you really live longer if you eat well?

A good diet can do wonders for health, but it is still unclear if it actually promotes longevity. Populational studies have found that a healthy diet can decrease the risk of getting cancer, cardiovascular diseases, and type 2 diabetes, and it is associated with lower mortality [2]. However, this is not exactly the same. Proper lifespan studies in humans are complicated by us being an exceptionally long-lived species.

To overcome this limitation, scientists have come up with biological clocks: single or composite biomarkers that supposedly show the body’s physical rate of aging. The difference between a person’s chronological and biological age is that person’s age acceleration.

One of the most popular types of biological clocks uses DNA methylation, the addition of a methyl group to the nucleotides that compose DNA [3]. DNA methylation patterns correlate with chronological age and mortality amazingly well, although the mechanism behind this correlation is not fully understood.

This new study, led by researchers from Stanford University and the company TruDiagnostics, might be the first to compare the effects of a wholesome vegan diet to a wholesome omnivorous diet on age acceleration as measured by methylation clocks. Moreover, the researchers used pairs of twins, which allowed them to automatically control for genetic, age, and sex differences.

Vegans age slower

Generally healthy twins in 21 pairs were put on either a vegan or omnivorous diet for eight weeks. The researchers tried making the diets as healthy as possible, such as by avoiding ultraprocessed food.

For their analysis, the scientists used multiple well-established methylation clocks, such as the second-generation blood and skin Horvath clock, GrimAge, PhenoAge, and DunedinPACE. They also calculated the individual ages of 11 organs and systems (heart, lung, kidney, liver, brain, immune, inflammatory, blood, musculoskeletal, hormone, and metabolic) along with their composite: Systems Age.

At the end of the experiment, GrimAge, PhenoAge, and DunedinPACE showed a marked decrease in average age acceleration in the vegan cohort but not in the omnivorous cohort. Interestingly, the most significant decrease was clocked by DunedinPACE, which is specifically designed to measure epigenetic age acceleration. Significant biological age reductions were also observed exclusively in the vegan cohort for 5 out of these 11 systems (inflammation, heart, hormone, liver, and metabolic) as well as for System Age.

Telomeres and other metrics

Because of its status as a hallmark of aging, the researchers also measured telomere length. By the end of the eighth week, the vegan group had significantly longer telomeres than the omnivorous group.

The difference in diet did not induce profound changes in the relative abundance of various immune cells. Among 12 immune cell subtypes, only basophil levels increased slightly in the vegan group and dropped even more slightly in the omnivorous group. Basophil abundance is related to inflammation, and the researchers cautiously note that their finding “contrasts with studies emphasizing the immunomodulatory benefits of plant-based diets.”

While genetic differences are commonly associated with an increased or decreased risk of various conditions, certain methylation changes show similar correlations. The researchers analyzed two methylation loci associated with type 2 diabetes. The vegan diet produced pro-diabetes changes in methylation in one locus, and anti-diabetes changes in the other.

Another novel approach in this study was the use of epigenetic biomarker proxies (EBPs), epigenetic values that correlate with certain biomarkers instead of the biomarkers themselves. For example, the EBP for C-reactive protein, the most popular marker of inflammation, was significantly lower in the vegan group. This is consistent with previous research that has tied a vegan diet to lower inflammation.

This study had multiple limitations, most notably a small sample size and a short intervention duration. It would be interesting to see the effect of a vegan diet on the epigenome over a longer period. Yet, the results sit well with the growing evidence that vegan diet, when properly done, confers significant health benefits.

In this study, we sought to elucidate the impact of a “healthy vegan” or a “healthy omnivorous diet” on epigenetic age, telomere length, immune cell subsets, and type 2 diabetes (T2D) risk-associated CpGs, building on current knowledge of nutrition on both diets. Our findings reveal distinct responses to vegan and omnivore diets, aligning with existing literature on the subject. Notably, the vegan cohort exhibited a significant decrease in epigenetic age acceleration, as demonstrated by reductions in multiple epigenetic aging clocks.

We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. We are committed to responsible journalism, free from commercial or political influence, that allows you to make informed decisions about your future health.

All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future. You can support us by making a donation or in other ways at no cost to you.

Literature

[1] Dwaraka, V. B., Aronica, L., Carreras-Gallo, N., Robinson, J. L., Hennings, T., Carter, M. M., … & Gardner, C. D. (2024). Unveiling the epigenetic impact of vegan vs. omnivorous diets on aging: insights from the Twins Nutrition Study (TwiNS). BMC medicine, 22(1), 301.

[2] Shan, Z., Wang, F., Li, Y., Baden, M. Y., Bhupathiraju, S. N., Wang, D. D., … & Hu, F. B. (2023). Healthy eating patterns and risk of total and cause-specific mortality. JAMA internal medicine, 183(2), 142-153.

[3] Bell, C. G., Lowe, R., Adams, P. D., Baccarelli, A. A., Beck, S., Bell, J. T., … & Rakyan, V. K. (2019). DNA methylation aging clocks: challenges and recommendations. Genome biology, 20, 1-24.